申请人:Shionogi & Co., Ltd.
公开号:US04560684A1
公开(公告)日:1985-12-24
1,4-Benzodiazepine derivatives of the formula: ##STR1## (in which R.sup.1 is pyrrolidinyl or piperidinyl each optionally substituted by C.sub.1-3 alkyl, phenyl-C.sub.1-3 alkyl, C.sub.1-5 alkanoyl, or C.sub.2-5 alkoxycarbonyl, R.sup.2 is hydrogen, hydroxy, or acetoxy, R.sup.3 is C.sub.1-3 alkyl, phenyl-C.sub.1-3 alkyl, or phenyl optionally substituted by one or two halogens, X is hydrogen, halogen, C.sub.1-3 alkyl, C.sub.1-3 alkoxy, nitro, trifluoromethyl, or di-C.sub.1-3 alkyl-amino, and n is 1 or 2) or pharmaceutically acceptable acid addition salts thereof, which are useful as a psychotropic agent such as anti-depressant or anxiolytic agent can be prepared from several routes.
1,4-苯二氮卓啉衍生物的化学式:##STR1##(其中R.sup.1为吡咯烷基或哌啶基,每个基团可选择地被C.sub.1-3烷基、苯基-C.sub.1-3烷基、C.sub.1-5烷酰基或C.sub.2-5烷氧羰基取代,R.sup.2为氢、羟基或乙酰氧基,R.sup.3为C.sub.1-3烷基、苯基-C.sub.1-3烷基或苯基,可选择地被一个或两个卤素取代,X为氢、卤素、C.sub.1-3烷基、C.sub.1-3烷氧基、硝基、三氟甲基或二个C.sub.1-3烷基-氨基,n为1或2)或其药学上可接受的酸盐,可用作精神药物,如抗抑郁剂或抗焦虑剂,可以通过几种途径制备。